In eleven patients (14%), the three investigators disagreed when estimating the allergic nature of the symptoms. Ten out of forty-four patients (23%), unanimously predicted not to be allergic, had high levels of total serum IgE and skin tests and RAST clearly positive for one or more ...
Conclusion The strong correlations suggest that the RCAT alone is equivalent to the RQLQ with respect to patients' symptom control and quality of life. Patients with uncontrolled symptoms can be identified using the RCAT. Hence, the physician can decide whether symptomatic therapy can be ...
as well as the promotion of food safety. During the last 20 years, the studies implicating the additives contained in foods and medicine as a causative factor of allergic reactions have been proliferated considerably. In this review, we aimed to overview all of...
CONCLUSION: The strong correlation suggests that the RCAT alone is equivalent to the RQLQ with respect to patients' symptom control and quality of life. Patients with uncontrolled symptoms can be identified using the RCAT. Hence, the physician can decide whether symptomatic therapy can be ...
Patients receiving a non-conform therapeutic regime reported a mean improvement in nasal symptoms of 4.58 points of a possible 9. Applying the guidelines strictly, by supplementing additional treatment modalities according to the severity of the symptoms of rhinitis, did not result in any additional ...
peptide immunotherapysubcutaneous immunotherapyBackground Immunotherapy with peptide hyddoi:10.1111/all.13433Msges, R.Bachert, C.Panzner, P.Calderon, M. A.Haazen, L.Pirotton, S.Wathelet, N.Durham, S. R.Bonny, M.‐A.Legon, T.Allergy...
Background A relevant proportion of allergic rhinoconjunctivitis (ARC) patients experience recurrent symptoms after successfully completing allergen immunotherapy ( AIT ). This prospective, controlled, noninterventional study used internationally standardized instruments to determine the clinical effects of a pre...
Ectoine significantly improved the singular symptoms "sneezing," "watery eyes" and "itchy eyes" (p ≤ 0.021) as well as "itchy ear/palate" (p = 0.036) in comparison to placebo. Mean cross sectional areas of the nasal cavity were reduced to a lesser extent after treatment with ectoine (...
Background A relevant proportion of allergic rhinoconjunctivitis (ARC) patients experience recurrent symptoms after successfully completing allergen immunotherapy (AIT). This prospective, controlled, noninterventional study used internationally standardized instruments to determine the clinical effects of a pre...